K.J. Harrison & Partners Inc Kiromic Biopharma, Inc. Transaction History

K.J. Harrison & Partners Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$0.26 - $0.87 $12,540 - $41,962	-48,233 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$0.6 - $1.82 $13,200 - $40,040	22,000 Added 83.86%	48,233 $41,000
Q4 2021 Jan 26, 2022	BUY	$1.53 - $3.12 $14,123 - $28,800	9,231 Added 54.29%	26,233 $40,000
Q3 2021 Nov 05, 2021	BUY	$2.69 - $4.94 $45,735 - $83,989	17,002 New	17,002 $52,000

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $16M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

Stay updated on K.J. Harrison & Partners Inc with notifications on news.